Entreprise · 09/07/20041 min de lecture
Notice of Approval of Abbreviated New Animal Drug Application; Oxytocin Injection
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration's Center for Veterinary Medicine (CVM) is providing notice that it has approved an original abbreviated new animal drug application (ANADA) filed by Cross Vetpharm Group, Ltd. The ANADA provides for the veterinary prescription use of oxytocin injectable solution in ewes, sows, cows, and horses. The applicable section of the regulation did not require amendment.